Clinical Trial Update: Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating CVI-LM001 for hyperlipidemia; safety and efficacy data are not disclosed in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• CVI-LM001

Snippet

Sponsor: CVI Pharmaceuticals | Conditions: Hyperlipidemia | Phase 2 | Status: UNKNOWN